Effects of lorazepam on emotional reactivity, performance, and vigilance in subjects with high or low anxiety

Journal of Clinical Psychopharmacology

Volumn 20, Issue 2, 2000, Pages 226-233

  Garcia, Christine ^b   Micallef, Joelle ^b   Dubreuil, Diane ^b   Philippot, Pierre ^a   Jouve, Elisabeth ^b   Blin, Olivier ^b  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b TIMONE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; LORAZEPAM; PLACEBO;

ADULT; ALERTNESS; ANGER; ANXIETY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EMOTION; FEAR; FEMALE; HAMILTON SCALE; HAPPINESS; HUMAN; LONELINESS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; RESPONSE TIME;

ADULT; ANTI-ANXIETY AGENTS; ANXIETY DISORDERS; AROUSAL; ATTENTION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; EMOTIONS; FEMALE; HUMANS; LORAZEPAM; MALE; NEUROPSYCHOLOGICAL TESTS;

EID: 0034038465     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-200004000-00016     Document Type: Article

References (40)

1. Mellinger GD, Balter MB, Uhlenhuth EH. Prevalence and correlates of the long-term regular use of anxiolytics. JAMA 1984;251:375-9.
2. Schweizer E, Rickeis K, Uhlenhuth EH. Issues in the long-term treatment of anxiety disorders. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: the fourth generation of progress. New York: Raven Press, 1995:1349-59.
3. Woods JH, Katz JL, Winger G. Benzodiazepines: use, abuse, and consequences. Pharmacol Rev 1992;44:151-347.
4. Shader RI, Greenblatt DJ. Use of benzodiazepines in anxiety disorders. N Engl J Med 1993;13:1398-405.
5. Jaffe JH. Drugs dependence: opioids, nonnarcotic, nicotine (tobacco), and caffeine. In: Kaplan HI, Sadock BJ, eds. Comprehensive textbook of psychiatry, vol 1, 5th ed. Baltimore: Williams & Wilkins, 1989:642-86.
6. Ameer B, Greenblatt DJ. Lorazepam: a review of its clinical pharmacological properties and therapeutic uses. Drugs 1981;21: 161-200.
7. Garcia C, Philippot P, Lacarelle B, Valli M, Rime B, Bruguerolle B, Blin O. Effects of lorazepam on film-induced differentiated emotions. Fundam Clin Pharmacol 1997;11:466-75.
8. Philippot P. Inducing and assessing differentiated emotion feeling states in the laboratory. Cogn Emotion 1993;7:171-93.
9. Garcia C, Azorin JM, Blin O. Psychopathologie quantitative des affects et des émotions: revue des échelles d'évaluation et des méthodes d'induction émotionnelle. Encephale 1997;23:119-30.
10. Bourin M, Cou'toux Du Tertre A, Colombel MC, Auget JL. Effects of low doses of lorazepam on psychometric tests in healthy volunteers. Int Clin Psychopharmacol 1994;9:83-8.
11. Bourin M, Colombel MC, Malinge M. Lorazepam 0.25 mg twice a day improves aspects of psychometric performance in healthy volunteers. J Psychopharmacol 1995;9:209-15.
12. Nakano S, Ogawa N, Kawazu Y, Osato E. Effects of antianxiety drug and personality on stress-inducing psychomotor performance test. J Clin Pharmacol 1978;2:125-30.
13. Clyde CA. The influence of personality on response to low doses of benzodiazepines. In: Clobazam: Royal Society of Medicine International Congress and Symposium series no. 43. London: Academic Press Inc. and The Royal Society of Medicine, 1981:75-86.
14. Desai N, Taylor-Davies A, Barnett DB. The effects of diazepam and oxprenolol on short-term memory in individuals of high and low state anxiety. Br J Clin Pharmacol 1983;15:197-202.
15. Koeppen D, Netter P, Fischer C. Individual differences in the effect of clobazam on memory functions. Pharmacopsychiatry 1985;18:12-4.
16. Cattell RB, Scheier IH. The nature of anxiety: a review of thirteen multivariate analyses comprising 814 variables. Psychol Rep 1958;4:351-88.
17. Linnoila M, Erwin C, Brendle A, Simpson D. Psychomotor effects of diazepam in anxious patients and healthy volunteers. J Clin Psychopharmacol 1983;3:88-96.
18. Danjou P, Warot D, Hergueta T, Lacomblez L, Bouhours P, Puech AJ. Comparative study of the psychomotor and antistress effects of ritanserin, alprazolam and diazepam in healthy subjects: some trait anxiety-independent responses. Int Clin Psychopharmacol 1992;7:73-9.
19. Cattell RB. Validation and intensification of the Sixteen Personality Factor Questionnaire. J Consult Psychol 1956;12:205-14.
20. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50-5.
21. Lazarus RS. Cognition and motivation in emotion. Am Psychol 1991;46:352-67.
22. Hindmarch I, Gudgeon AC. The effects of clobazam and lorazepam on aspects of psychomotor performance and car handling ability. Br J Clin Pharmacol 1980;10:145-50.
23. Wechsler D. Manual for the Wechsler Adult Intelligence Scale. New York: The Psychological Corporation, 1955.
24. Pau O, Guidon-Attali A, Viviand X, Lacarelle B, Bouffier C, Francois G. Pharmacodynamic properties of propofol during recovery from anaesthesia. Acta Anaesthesiol Scand 1992;36:62-6.
25. Gross JJ, Levenson RW. Elicitation using films. Cogn Emotion 1995;9:87-108.
26. Ouss L, Carton S, Jouvent R, Widlöcher D. Traduction et validation de l'échelle d'émotions différentielles d'Izard. Encephale 1990;16:453-8.
27. Izard CE, Dougherty FE, Bloxom BM, Kotsch NE. The Differential Emotions Scale: a method of measuring the meaning of subjective experience of discrete emotions. Nashville: Vanderbilt University, Department of Psychology, 1974.
28. McHugo GJ, Smith GA, Lanzetta JT. The structure of self-reports of emotional responses to film segments. Motiv Emotion 1982; 6:365-85.
29. Miller G, Gallanter E, Pribam KH. Plans and the structure of behavior. New York: Holt, 1960.
30. Mandler G. Mind and body: psychology of emotion and stress. New York: WW Norton, 1984.
31. Gray JA. A theory of anxiety: the role of the limbic system. Encephale 1983;9:161B-6B.
32. Pull CB, Widlöcher D. Anxiety-related inhibition. Psychiatr Psychobiol 1989;4:1-11.
33. Bourin M, Colombel MC, Guitton B. Alprazolam 0.125 mg twice a day improves aspects of psychometric performance in healthy volunteers. J Clin Psychopharmacol 1998;18:364-72.
34. Deijen JB, Heemstra ML, Orlebeke JF. Residual effects of lormetazepam on mood and performance in healthy elderly volunteers. Eur J Clin Pharmacol 1991;40:267-71.
35. Bourin M, Hubert C, Colombel MC, Larousse C. Residual effects of temazepam versus nitrazepam on memory and vigilance in the normal subject. Hum Psychopharmacol 1987;2:185-9.
36. Hindmarch I. Some aspects of clobazam on human psychomotor performance. Br J Clin Pharmacol 1979;7:77S-82S.
37. Bourin M, Auget JL, Colombel MC, Larousse C. Effects of single oral doses of bromazepam, buspirone and clobazam on performance tasks and memory. Neuropsychobiology 1989;22: 141-5.
38. Sunderland T, Weingartner H, Cohen RM, Tariot PN, Newhouse PA, Thompson KE, Lawlor BA, Mueller E. Low-dose oral lorazepam administration in Alzheimer subjects and age-matched controls. Psychopharmacology (Berl) 1989;99:129-33.
39. Kunsman GW, Manno JE, Manno BR, Kunsman CM, Przekop MA. The use of microcomputer-based psychomotor tests for the evaluation of benzodiazepine effects on human performance: a review with emphasis on temazepam. Br J Clin Pharmacol 1992; 34:289-301.
40. Janke W, Debus G, Longo N. Differential psychopharmacology of tranquilizing and sedating drugs. Mod Probl Pharmacopsychiatry 1979;14:13-98.